National strategy process"Innovations in Medical Technology"

Steering Committee of the "Innovations in Medical Technology" national strategy process

The Steering Committee will head the strategy process. It convenes five working groups, each focusing on a different stage in the innovation chain - be it medical equipment, research and development, clinical validation, financing by statutory health insurance companies, or tapping the global health care markets. The Steering Committee identifies and defines the core topics to be discussed in the respective working groups. It also reviews the results produced in the groups and will compile these results in a final report to be issued in late 2012.

The members of the Steering Committee include state secretaries from the three federal ministries as well as high-ranking stakeholders from industry, science and the health care system:

• Dr. med. Ute Brauer    
  Senior Vice President Medical Scientific Affairs, B. Braun Melsungen AG
• Ernst Burgbacher   
  Parliamentary State Secretary to the Federal Minister of Economics and Technology and Federal Government Commissioner for SMEs and Tourism
• Dr. Dieter R. Dannhorn  
  Managing Director, mdt medical device testing GmbH
• Prof. Dr. Wolfgang Hoffmann   
  Head of Section Epidemiology of Health Care and Community Health, Institute for Community Medicine, University of Greifswald Medical School
• Thomas Ilka   
  State Secretary at the Federal Ministry of Health
• Prof. Dr. Norbert Klusen   
  Chairman of the Board, Techniker Krankenkasse
• Dr. Michael Kuhn   
  Vice President Technology Strategy, Philips Healthcare
• Dr. Kai Kück   
  Head of Research, Drägerwerk AG & Co. KG
• Wolfgang Pföhler    
  Chairman of Board of Directors, Rhön-Klinikum AG
• Prof. Dr. Franz Porzsolt   
  Head of Working Group, Clinical Economics, Ulm University
• Prof. Dr. med. Dipl.-Ing. Thomas Schmitz-Rode  
  Director, Institute of Applied Medical Engineering, RWTH Aachen
• Dr. Georg Schütte   
  State Secretary at the Federal Ministry of Education and Research
• Dr. Thomas Schweins   
  Senior Vice President, Marketing & Strategy, Qiagen GmbH
• Prof. Dr. Peter C. Scriba   
  Chairman, Scientific Advisory Board, German Medical Association
• Cord Friedrich Stähler
  Chief Technology Officer, Siemens AG Healthcare
• Dr. Hans-Jürgen Wildau   
  Vice President Health Services, BIOTRONIK SE & Co. KG
• Dr. Walter-G. Wrobel   
  Managing Director, Retina Implant AG

A central contact office will provide support to the federal ministries, the Steering Committee and the working groups during implementation of the process. The Contact Office for the Strategy Process in Medical Technology is located at the Berlin offices of  VDI Technologiezentrum GmbH .